DM
Deerfield Management Portfolio holdings
AUM
$5.51B
This Quarter Return
-10.64%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$2.35B
AUM Growth
+$2.35B
(-1.2%)
Cap. Flow
+$239M
Cap. Flow
% of AUM
10.19%
Top 10 Holdings %
Top 10 Hldgs %
36.4%
Holding
126
New
15
Increased
30
Reduced
16
Closed
18
Top Buys
| 1 |
AVXS
AveXis, Inc. Common Stock
AVXS
|
$60.9M |
| 2 |
Editas Medicine
EDIT
|
$59M |
| 3 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
$49.1M |
| 4 |
Viatris
VTRS
|
$36M |
| 5 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$34.1M |
Top Sells
| 1 |
DYAX
DYAX CORPORATION
DYAX
|
$84.3M |
| 2 |
Teva Pharmaceuticals
TEVA
|
$53.5M |
| 3 |
Charles River Laboratories
CRL
|
$30.3M |
| 4 |
GHDX
Genomic Health, Inc.
GHDX
|
$28.5M |
| 5 |
Pacira BioSciences
PCRX
|
$28.5M |
Sector Composition
| 1 | Healthcare | 69.81% |
| 2 | Financials | 4.2% |
| 3 | Technology | 0.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Voyager Therapeutics
VYGR
$186M
| $2.05M | 0.09% |
235,294
| – | – |
|
77
Aldeyra Therapeutics
ALDX
$351M
| $1.98M | 0.08% |
471,259
-219,279
| -32% | -$919K |
|
|
TRIL
78
DELISTED
Trillium Therapeutics Inc.
TRIL
| $1.59M | 0.07% |
172,307
| – | – |
|
|
AGRX
79
DELISTED
Agile Therapeutics, Inc
AGRX
| $1.55M | 0.07% |
+250,000
| New | +$1.55M |
|
80
Trupanion
TRUP
$1.99B
| $1.53M | 0.07% |
155,236
-906,978
| -85% | -$8.93M |
|
81
Alphatec Holdings
ATEC
$2.35B
| $1.2M | 0.05% |
4,982,738
| – | – |
|
82
CareDx
CDNA
$727M
| $1.14M | 0.05% |
229,000
| – | – |
|
|
AGN
83
DELISTED
Allergan plc
AGN
| $938K | 0.04% |
+3,500
| New | +$938K |
|
|
STRM
84
DELISTED
Streamline Health Solutions
STRM
| $935K | 0.04% |
662,971
| – | – |
|
85
Veracyte
VCYT
$2.39B
| $892K | 0.04% |
165,097
-227,050
| -58% | -$1.23M |
|
86
Cidara Therapeutics
CDTX
$1.66B
| $873K | 0.04% |
68,779
-50,677
| -42% | -$643K |
|
87
Pfizer
PFE
$142B
| $741K | 0.03% |
+25,000
| New | +$741K |
|
|
ADYX
88
DELISTED
Adynxx, Inc. Common Stock
ADYX
| $547K | 0.02% |
667,246
-1,212,888
| -65% | -$994K |
|
|
PTN
89
DELISTED
Palatin Technologies
PTN
| $532K | 0.02% |
985,693
-1,014,307
| -51% | -$547K |
|
|
WMGI
90
DELISTED
Wright Medical Group Inc
WMGI
| $498K | 0.02% |
+30,000
| New | +$498K |
|
|
RNVA
91
DELISTED
Rennova Health, Inc.
RNVA
| $265K | 0.01% |
353,933
-205,498
| -37% | -$154K |
|
|
OCRX
92
DELISTED
Ocera Therapeutics, Inc.
OCRX
| $221K | 0.01% |
+75,293
| New | +$221K |
|
93
Apyx Medical
APYX
$75.3M
| – | – |
-688,229
| Closed | -$1.45M |
|
94
Centene
CNC
$14.5B
| – | – |
-244,000
| Closed | -$16.1M |
|
95
Cencora
COR
$56.5B
| – | – |
-3,000
| Closed | -$311K |
|
|
96
Charles River Laboratories
CRL
$8.04B
| – | – |
-377,188
| Closed | -$30.3M |
|
97
Gilead Sciences
GILD
$140B
| – | – |
0
| – | – |
|
98
Pacific Biosciences
PACB
$384M
| – | – |
-1,388,000
| Closed | -$18.2M |
|
|
99
Pacira BioSciences
PCRX
$1.2B
| – | – |
-371,000
| Closed | -$28.5M |
|
|
100
Teva Pharmaceuticals
TEVA
$21.5B
| – | – |
-815,000
| Closed | -$53.5M |
|